Cello Health are pleased to announce our Gold Sponsorship of BioTrinity 2018
Cello Health are pleased to announce our Gold Sponsorship of this years BioTrinity event on April 23–25 in London.
Stop by booth P25 to speak to one of our team about capabilities and experience in supporting BioPharm clients from asset identification or acquisition through to informing the Phase 3 programme.
In addition to our booth presence, Mike Rice who heads our Advanced Therapies and Rare Diseases practices out of Defined Health, will be participating in the panel “Cell & Gene Therapy – Cost v Rarity” on Wednesday 25 April from 11:50. Mike has 20 years’ experience in biotech ventures defining strategic development and early commercial strategy for academic and biotech inventions pertaining to nucleic acids, gene therapy and cellular platforms applied across monogenetic diseases and oncology. He is a member of the American Society of Gene and Cell Therapy and the Alliance for Regenerative Medicine, and is looking forward to an engaging panel session.
Finally, if you would like to meet for a personal one-to-one session to discuss your specific challenges and how we may be able to help, we will be arranging partnering meetings. Adrian Walford, VP Business Development, Cello Health will be on site to listen and understand your current situation and provide advice on how to continue to drive you forward.
To schedule a meeting ahead of time please email firstname.lastname@example.org.